Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sulfur hexafluoride + tissue plasminogen activator
- Development stage
- Unknown
- Lead developer
- Bracco
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Intravenous, Intracatheter
01
Overview
This is a combination of two agents, sulfur hexafluoride and tissue plasminogen activator (tPA). Sulfur hexafluoride is an inert gas commonly used as a contrast agent in ultrasound imaging. Tissue plasminogen activator is a serine protease enzyme that catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for clot breakdown. tPA is used clinically as a thrombolytic drug to dissolve blood clots in conditions such as acute ischemic stroke, myocardial infarction, and massive pulmonary embolism[2][3][4]. The combination may be under investigation for enhanced thrombolysis or targeted delivery applications; however, there are no approved pharmaceutical products combining these two agents.
- Other names
- tPA + SF6rt-PA + SF6
02
Targets
PLG (Plasminogen)Fibrin (Factor Ia)
Beyond the preview
Go deeper on sulfur hexafluoride + tissue plasminogen activator.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sulfur hexafluoride + tissue plasminogen activator.